Prognotic impact of serum follistatin in patients with hepatocellular carcinoma

Matrix Metalloproteinases Contribute Distinct Roles in Neuroendocrine Prostate Carcinogenesis, Metastasis, and Angiogenesis Progression

(2010) L. E. Littlepage et al.   CANCER RESEARCH

Serum follistatin in patients with prostate cancer metastatic to the bone

(2010) Francesca Maria Tumminello et al.   CLINICAL & EXPERIMENTAL METASTASIS

Increased Expression of a Disintegrin and Metalloprotease-9 in Hepatocellular Carcinoma: Implications for Tumor Progression and Prognosis

(2010) K. Tao et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Current Management of Hepatocellular Cancer

(2010) Bernardino Rampone et al.   Current Oncology Reports

AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease

(2008) Gary Beale et al.   BMC CANCER

Follistatin Suppresses the Production of Experimental Multiple-Organ Metastasis by Small Cell Lung Cancer Cells in Natural Killer Cell-Depleted SCID Mice

(2008) H. Ogino et al.   CLINICAL CANCER RESEARCH

Prognostic value of pretreatment levels of tumor markers for hepatocellular carcinoma on survival after curative treatment of patients with HCC

(2008) Hidenori Toyoda et al.   JOURNAL OF HEPATOLOGY

Parkin as a tumor suppressor gene for hepatocellular carcinoma

(2008) M Fujiwara et al.   ONCOGENE